グルコース-6-リン酸脱水酵素欠乏症と自閉症スペクトル障害との関連を調べる
Maitha Abdulla Alshamsi1, Maitha Tareq Al Teneiji1, Subhranshu Sekhar Kar2
1RAK College of Medical Sciences, RAK Medical and Health Sciences University, Ras Al-Khaimah P.O. Box 11172, United Arab Emirates.
Children (Basel, Switzerland)
|August 28, 2025
まとめ
G6PD欠乏症は自閉症スペクトル障害 (ASD) と関連している可能性があります. G6PD欠乏症とASDの潜在的な関連として,酸化ストレスと葉酸代謝を調査するためにさらなる研究が必要です.
科学分野:
- 神経科学
- 遺伝学
- 生物化学
背景:
- 自閉症スペクトル障害 (ASD) は複雑な神経発達状態です.
- グルコース6リン酸脱水素酶 (G6PD) 欠乏症は,一般的な赤血球酵素病です.
- 最近の研究では G6PD欠乏症とASDのような神経発達障害の関連が示唆されています
研究 の 目的:
- G6PD欠乏症とASDの関連性を調べる
- この2つの状態の関係に関する既存の文献をレビューする.
- G6PD欠乏症とASDを関連付ける潜在的な生物学的メカニズムを特定する.
主な方法:
- 科学文献の記述的レビュー
- PubMedとScopusのデータベースで検索したものです.
- G6PD欠乏症と自閉症を調査した研究の分析
主要な成果:
- G6PD欠乏症とASDの間の生物学的関連が示唆されている.
- 酸化ストレスと葉酸代謝は重要な分野として特定されています.
- G6PD欠乏症はASDにおけるリスク変容因子として作用する可能性があります.
結論:
- G6PD欠乏症とASDの潜在的な関連性については,さらなる調査が必要である.
- この関係を理解すると,臨床実務とリスク評価に意味があります.
- この関連性の性質を完全に解明するには,さらなる研究が必要です.
関連する概念動画
Autism Spectrum Disorder
335
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
335
Glucose Transporters
24.1K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
24.1K
Inborn Errors of Metabolism
240
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
240
Pedigree Analysis
85.1K
Overview
85.1K
Genome-wide Association Studies-GWAS
14.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.1K
Attention-Deficit/Hyperactivity Disorder
289
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
289


